Int J Sports Med, 2011; 32(10): 781-7, PMID: 21870317
Combined Effects of Whole-Body Vibration, Resistance Exercise, and Vascular Occlusion on Skeletal Muscle and Performance.
Item F, Denkinger J, Fontana P, Weber M, Boutellier U, Toigo M
Exercise Physiology, Institute of Human Movement Sciences and Sport, ETH Zurich, Switzerland.
Abstract
The purpose of this study was to evaluate the effects of a new high-intensity training modality comprised of vibration exercise with superimposed resistance exercise and vascular occlusion (vibroX) on skeletal muscle and performance. Young untrained women were randomized to either train in a progressive mode on 3 days per week for 5 weeks ( N=12) or to maintain a sedentary lifestyle ( N=9). VibroX increased peak cycling power (+9%, P=0.001), endurance capacity (+57%, P=0.002), ventilatory threshold (+12%, P<0.001), and end-test torque (+15%, P=0.002) relative to the sedentary group. Training load increased by 84.5% ( P<0.001) after vibroX. The increases were paralleled by increases in myosin heavy chain type 1 vastus lateralis muscle fiber cross-sectional area (+14%, P=0.031) and proportion (+17%, P=0.015), thigh lean mass (+4%, P=0.001), capillary-to-fiber ratio (+14%, P=0.003), and cytochrome c oxidase activity. Conversely, maximal values for oxygen consumption, cardiac output, isokinetic leg extension power and jumping power remained unaffected. Notably, vastus lateralis muscle adaptations were achieved with a very low weekly training volume. We conclude that vibroX quickly increases muscle (fiber) size, capillarization, and oxidative potential, and markedly augments endurance capacity in young women.Product groups: Galileo® Therapy Systems, Leonardo Mechanograph®, Galileo® Training Devices
Topics: Competitive Sports, Clinical Studies, Clinical Application, Competitive Sports, Wellness & Beauty, Fitness at Home, Fitness in the Studio, Osteoporosis, Disease Patterns, Physiotherapy & Rehabilitation, Training & Study Support, Diagnostics with Leonardo & pQCT, Basics, Training with Galileo®, Therapy & Prevention with Galileo®, Basic Research
Doc-ID: 2690,
